Monika Toma

6PUBLICATIONS
49CO-AUTHORS
Tumour immunologyHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jul 01, 2026
Selective sensitivity of Ph-like B-cell acute lymphoblastic leukemia to BRG1 inhibition identifies a therapeutic vulnerability.

|Jul 10, 2025
ADH5/ALDH2 dehydrogenases and DNA polymerase theta protect normal and malignant hematopoietic cells from formaldehyde challenge: therapeutic implications.

Jessica Atkins, Anna-Mariya Kukuyan, Monika Toma

|Sep 02, 2024
Star wars against leukemia: attacking the clones.

Monika M Toma, Tomasz Skorski

|Dec 08, 2023
4'-Ethynyl-2'-Deoxycytidine (EdC) Preferentially Targets Lymphoma and Leukemia Subtypes by Inducing Replicative Stress.

Marissa L Calbert, Gurushankar Chandramouly, Clare M Adams

|Jun 26, 2023
Simultaneous Targeting of DNA Polymerase Theta and PARP1 or RAD52 Triggers Dual Synthetic Lethality in Homologous Recombination-Deficient Leukemia Cells.

Katherine Sullivan-Reed, Monika M Toma, Malgorzata Drzewiecka

|Dec 29, 2022
DNA polymerase θ protects leukemia cells from metabolically induced DNA damage.

Umeshkumar Vekariya, Monika Toma, Margaret Nieborowska-Skorska

Pageof 1

Frequent Collaborators

4 joint publications

Tomasz Skorski

3 joint publications

Jessica Atkins

2 joint publications

Malgorzata Drzewiecka

2 joint publications

Emir Hadzijusufovic